Literature DB >> 2636669

Factors underlying abnormal zinc metabolism in uremia.

S K Mahajan1, E M Bowersox, D L Rye, D K Abu-Hamdan, A S Prasad, F D McDonald, K L Biersack.   

Abstract

Zinc balance studies were completed in ten hemodialyzed adult uremic patients and five normal controls to determine the cause of abnormal zinc metabolism in uremia. Subjects were fed standard hospital foods providing nutrients in amounts recommended for adult stable hemodialyzed patients. The amount of zinc in the diet was kept constant at 10 mg per day. After one week of stabilization, blood, urine, used dialysate (in patients on dialysis days) and stool samples were collected daily for the next two weeks. In comparison to controls, patients had lower plasma zinc levels (mean +/- SD, 112 +/- 10 vs. 82 +/- 12 micrograms/dl, P less than 0.01), lower urinary zinc excretion (560 +/- 120 vs. 40 +/- 20 mg/24 hrs, P less than 0.001) and higher fecal zinc losses (8.1 +/- 0.7 vs. 10.2 +/- 0.6 mg/24 hrs, P less than 0.01). Dialytic zinc losses were minimal (26 +/- 4 micrograms/treatment). During the study period, patients were in a negative zinc balance while normal controls maintained a positive zinc balance on 10 mg dietary zinc intake. These results demonstrate that augmented fecal zinc excretion in the presence of hypozincemia contributes to the negative zinc balance in hemodialyzed uremic patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2636669

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  7 in total

1.  Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia.

Authors:  Atsuyuki Tokuyama; Eiichiro Kanda; Seiji Itano; Megumi Kondo; Yoshihisa Wada; Hiroyuki Kadoya; Kengo Kidokoro; Hajime Nagasu; Tamaki Sasaki; Naoki Kashihara
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

2.  Effects of Zinc Acetate on Serum Zinc Concentrations in Chronic Liver Diseases: a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial and a Dose Adjustment Trial.

Authors:  Kazuhiro Katayama; Atsushi Hosui; Yoshiyuki Sakai; Minoru Itou; Yasushi Matsuzaki; Yoriyuki Takamori; Keiko Hosho; Tomomi Tsuru; Yasuhiro Takikawa; Kojiro Michitaka; Eishin Ogawa; Yoko Miyoshi; Toshifumi Ito; Shinobu Ida; Izumi Hamada; Katsunori Miyoshi; Hiroko Kodama; Tetsuo Takehara
Journal:  Biol Trace Elem Res       Date:  2019-08-07       Impact factor: 3.738

Review 3.  Trace elements in hemodialysis patients: a systematic review and meta-analysis.

Authors:  Marcello Tonelli; Natasha Wiebe; Brenda Hemmelgarn; Scott Klarenbach; Catherine Field; Braden Manns; Ravi Thadhani; John Gill
Journal:  BMC Med       Date:  2009-05-19       Impact factor: 8.775

Review 4.  Association of Zinc Deficiency with Development of CVD Events in Patients with CKD.

Authors:  Shinya Nakatani; Katsuhito Mori; Tetsuo Shoji; Masanori Emoto
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

5.  Prevalence of Zinc Deficiency in Japanese Patients on Peritoneal Dialysis: Comparative Study in Patients on Hemodialysis.

Authors:  Satoshi Shimizu; Ritsukou Tei; Masahiro Okamura; Nobuteru Takao; Yoshihiro Nakamura; Hidetaka Oguma; Takashi Maruyama; Hiroyuki Takashima; Masanori Abe
Journal:  Nutrients       Date:  2020-03-14       Impact factor: 5.717

6.  Association between Serum Zinc Levels and Clinical Index or the Body Composition in Incident Hemodialysis Patients.

Authors:  Tatsunori Toida; Reiko Toida; Shou Ebihara; Risa Takahashi; Hiroyuki Komatsu; Shigehiro Uezono; Yuji Sato; Shouichi Fujimoto
Journal:  Nutrients       Date:  2020-10-19       Impact factor: 5.717

7.  Carbon dioxide narcosis in the terminal stage of hemodialysis therapy: A case report with the possible pathophysiologies and the treatment methods.

Authors:  Akira Takahashi
Journal:  Clin Case Rep       Date:  2021-03-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.